Dennis Slamon

Dennis Slamon, MD, PhD

UCLA Medical Center

Financial Disclosure

Novartis

Consultant

Speaker

Grant Or Contract

Other

Pfizer

Consultant

Speaker

TORL BioTherapeutics

Executive Role

1200 Pharma

Executive Role

Other

Pfizer

Grant Or Contract

Other

BioMarin (ended May 2024)

Executive Role

BioMarin

Other

Amgen

Other

TORL BioTherapeutics

Other

Seattle Genetics

Other